X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23) 23
index medicus (22) 22
oncology (17) 17
male (13) 13
female (12) 12
multiple myeloma (11) 11
adult (10) 10
middle aged (10) 10
animals (9) 9
hematology (9) 9
aged (8) 8
bortezomib (8) 8
cancer (8) 8
apoptosis (7) 7
mice (7) 7
therapy (7) 7
apoptosis - drug effects (6) 6
cell proliferation - drug effects (6) 6
dexamethasone (6) 6
flow cytometry (6) 6
health aspects (6) 6
medicine, research & experimental (6) 6
adolescent (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
cell line, tumor (5) 5
cells, cultured (5) 5
chemotherapy (5) 5
expression (5) 5
thrombocytopenia (5) 5
activation (4) 4
blotting, western (4) 4
china (4) 4
differentiation (4) 4
gene expression (4) 4
human necessities (4) 4
immunology (4) 4
multiple myeloma - drug therapy (4) 4
recurrence (4) 4
research (4) 4
reverse transcriptase polymerase chain reaction (4) 4
studies (4) 4
survival (4) 4
treatment outcome (4) 4
aged, 80 and over (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
autolysosome (3) 3
autophagosome (3) 3
caspase (3) 3
caspases - metabolism (3) 3
cell biology (3) 3
cells (3) 3
clinical trials (3) 3
drug resistance (3) 3
epidemiology (3) 3
flux (3) 3
genetic aspects (3) 3
hematology, oncology and palliative medicine (3) 3
hygiene (3) 3
internal medicine (3) 3
kinases (3) 3
lc3 (3) 3
lymphocytes (3) 3
lymphomas (3) 3
lysosome (3) 3
medical colleges (3) 3
medical or veterinary science (3) 3
medicine & public health (3) 3
multicenter (3) 3
multiple myeloma - pathology (3) 3
neutropenia (3) 3
pathology (3) 3
pathway (3) 3
phagophore (3) 3
protein (3) 3
proteins (3) 3
relapse (3) 3
rna interference (3) 3
stem cells (3) 3
stress (3) 3
vacuole (3) 3
young adult (3) 3
actin (2) 2
adhesion (2) 2
administration, intravenous (2) 2
anemia (2) 2
articles (2) 2
biochemistry & molecular biology (2) 2
biology (2) 2
boronic acids - pharmacology (2) 2
cancer research (2) 2
case-control studies (2) 2
cell adhesion - drug effects (2) 2
cell and molecular biology (2) 2
cell cycle (2) 2
cell cycle checkpoints - drug effects (2) 2
cell growth (2) 2
cell migration (2) 2
cell transformation, neoplastic - drug effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Zhonghua nei ke za zhi, ISSN 0578-1426, 02/2016, Volume 55, Issue 2, pp. 92 - 93
Journal Article
by Klionsky, Daniel J and Abdalla, Fabio C and Abeliovich, Hagai and Abraham, Robert T and Acevedo-Arozena, Abraham and Adeli, Khosrow and Agholme, Lotta and Agnello, Maria and Agostinis, Patrizia and Aguirre-Ghiso, Julio A and Ahn, Hyung Jun and Ait-Mohamed, Ouardia and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akira, Shizuo and Al-Younes, Hesham M and Al-Zeer, Munir A and Albert, Matthew L and Albin, Roger L and Alegre-Abarrategui, Javier and Aleo, Maria Francesca and Alirezaei, Mehrdad and Almasan, Alexandru and Almonte-Becerril, Maylin and Amano, Atsuo and Amaravadi, Ravi K and Amarnath, Shoba and Amer, Amal O and Andrieu-Abadie, Nathalie and Anantharam, Vellareddy and Ann, David K and Anoopkumar-Dukie, Shailendra and Aoki, Hiroshi and Apostolova, Nadezda and Arancia, Giuseppe and Aris, John P and Asanuma, Katsuhiko and Asare, Nana Y.O and Ashida, Hisashi and Askanas, Valerie and Askew, David S and Auberger, Patrick and Baba, Misuzu and Backues, Steven K and Baehrecke, Eric H and Bahr, Ben A and Bai, Xue-Yuan and Bailly, Yannick and Baiocchi, Robert and Baldini, Giulia and Balduini, Walter and Ballabio, Andrea and Bamber, Bruce A and Bampton, Edward T.W and Juhász, Gábor and Bartholomew, Clinton R and Bassham, Diane C and Bast, Robert C and Batoko, Henri and Bay, Boon-Huat and Beau, Isabelle and Béchet, Daniel M and Begley, Thomas J and Behl, Christian and Behrends, Christian and Bekri, Soumeya and Bellaire, Bryan and Bendall, Linda J and Benetti, Luca and Berliocchi, Laura and Bernardi, Henri and Bernassola, Francesca and Besteiro, Sébastien and Bhatia-Kissova, Ingrid and Bi, Xiaoning and Biard-Piechaczyk, Martine and Blum, Janice S and Boise, Lawrence H and Bonaldo, Paolo and Boone, David L and Bornhauser, Beat C and Bortoluci, Karina R and Bossis, Ioannis and Bost, Frédéric and Bourquin, Jean-Pierre and Boya, Patricia and Boyer-Guittaut, Michaël and Bozhkov, Peter V and Brady, Nathan R and Brancolini, Claudio and Brech, Andreas and Brenman, Jay E and Brennand, Ana and Bresnick, Emery H and Brest, Patrick and Bridges, Dave and Bristol, Molly L and Brookes, Paul S and Brown, Eric J and Brumell, John H and ... and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Geriatrik and Institutionen för medicin och hälsa and Farmakologi and Experimentell patologi and Hälsouniversitetet and Cellbiologi
Autophagy, ISSN 1554-8627, 04/2012, Volume 8, Issue 4, pp. 445 - 544
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 03/2017, Volume 10, Issue 1, pp. 69 - 5
Journal Article
Journal Article
Cancer Research and Clinic, ISSN 1006-9801, 11/2016, Volume 28, Issue 11, pp. 785 - 789
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 07/2017, Volume 10, Issue 1, pp. 137 - 13
Background: The China Continuation study was a separate regional expansion of the global, double-blind, placebo-controlled, randomized phase III TOURMALINE-MM1... 
China | Proteasome inhibitor | Multiple myeloma | Oral | Overall survival | Ixazomib | Progression-free survival | Relapsed/refractory | MORTALITY | MULTICENTER | PROTEASOME INHIBITOR IXAZOMIB | CANCER INCIDENCE | THERAPY | ONCOLOGY | HEMATOLOGY | Glycine - analogs & derivatives | Glycine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Dexamethasone - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - pharmacokinetics | Thalidomide - analogs & derivatives | Angiogenesis Inhibitors - administration & dosage | Multiple Myeloma - drug therapy | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Angiogenesis Inhibitors - adverse effects | Glycine - administration & dosage | Glycine - pharmacokinetics | Multiple Myeloma - epidemiology | Thalidomide - adverse effects | Dexamethasone - administration & dosage | Double-Blind Method | Placebo Effect | Boron Compounds - pharmacokinetics | Angiogenesis Inhibitors - pharmacokinetics | China - epidemiology | Thalidomide - administration & dosage | Dexamethasone - pharmacokinetics | Disease-Free Survival | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Boron Compounds - adverse effects | Aged | Thalidomide - therapeutic use | Boron Compounds - therapeutic use | Complications and side effects | Dosage and administration | Dexamethasone | Research | Drug therapy | Thrombocytopenia | Working groups | Laboratories | Anemia | Toxicity | Clinical trials | FDA approval | Survival | Cytogenetics | Drug dosages | Neutropenia
Journal Article
Journal of Investigative Medicine, ISSN 1081-5589, 04/2018, Volume 66, Issue 4, pp. 762 - 767
This study aimed to investigate clinical characteristics and survival outcomes of primary cutaneous T-cell lymphoma (CTCL) in HIV-infected and non-HIV-infected... 
UNITED-STATES | MEDICINE, RESEARCH & EXPERIMENTAL | surveillance epidemiology and end results (SEER) program | survival | AIDS | CANCER | MEDICINE, GENERAL & INTERNAL | HIV | ERA | ACTIVE ANTIRETROVIRAL THERAPY | DISEASE | NON-HODGKIN-LYMPHOMA | MALIGNANCIES | risk | SKIN | EPIDEMIOLOGY | primary cutaneous T-cell lymphoma
Journal Article